An Idaho law targeted fentanyl dealers. Prosecutors are using it to charge users, too
An InvestigateWest review found at least 30 people charged with trafficking without evidence of selling or distribution. They face mandatory minimum prison terms.
The Senate Finance Committee has launched an inquiry into financial ties between producers of prescription painkillers and the doctors and patient advocacy groups that help to set guidelines for drug use, the New York Times reported on Tuesday.
The manufacturers of OxyContin, Percocet, and Duragesic are among the targets of the inquiry, which is led by Sen. Max Baucus (D-Montana) and Sen. Charles E. Grassley (R-Iowa). The Pain and Policy Studies Group at the University of Wisconsin and the American Pain Foundation, which closed last week, according to its website, also received letters asking for information about ties to drug makers.
The investigation comes amidst the increasing number of prescription drug overdoses that InvestigateWest reported on in January.
ProPublica’s Dollars for Docs project, which makes information about drug company payments to doctors publicly accessible, has led to a flurry of stories in the media, and the Seattle Times recently won a Pulitzer for its investigation into methadone and pain control.
More coverage of the Senate inquiry: Reuters, Pharmalot, ProPublica.
The story you just read is only possible because readers like you support our mission to uncover truths that matter. If you value this reporting, help us continue producing high-impact investigations that drive real-world change. Your donation today ensures we can keep asking tough questions and bringing critical issues to light. Join us — because fearless, independent journalism depends on you!
— Jacob H. Fries, executive director
DonateCancel anytime.
Subscribe to our weekly newsletters and never miss an investigation.